Draximage Dtpa 20 mg (Pentetic Acid POWDER FOR SOLUTION) 20 MG

Draximage DTPA 20 MG is a powder for solution used in medical imaging. This formulation, containing pentetic acid, is designed for inhalation and is manufactured by Jubilant Draximage Inc.

Strength

20 MG

Pack Size

10ML

Manufacturer / TM Owner

JUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMA

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Draximage DTPA 20 MG is primarily used in diagnostic imaging procedures. It is often employed to assess lung function and detect certain types of lung conditions. The solution is administered via inhalation, making it suitable for respiratory evaluations. What is Draximage DTPA used for? It is commonly utilized in scenarios where detailed imaging of the lungs is required.

Side Effects

When used as directed, Draximage DTPA 20 MG may help in providing clear images of the lungs. This can aid healthcare professionals in identifying and monitoring lung-related issues. The effects are typically observed during the imaging process, providing valuable insights into lung function and structure.

Precautions & Warnings

As with any medical product, it is important to handle Draximage DTPA 20 MG with care. Ensure that the solution is prepared and administered correctly to avoid any potential issues. Always follow the guidelines provided by healthcare professionals when using this product.

Avoid Interactions

Draximage DTPA 20 MG may interact with certain substances. It is advisable to inform healthcare providers about any other medications or supplements being taken to avoid potential interactions. Always consult with a healthcare professional before using this product.

Frequently Asked Questions

Draximage DTPA is used in diagnostic imaging to assess lung function and detect certain lung conditions.

Draximage DTPA is administered via inhalation as a powder for solution.

The common effects include providing clear images of the lungs, aiding in the identification and monitoring of lung-related issues.

Yes, it is important to handle the product carefully and follow the guidelines provided by healthcare professionals.

Yes, it may interact with certain substances, so it is advisable to inform healthcare providers about any other medications being taken.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.